Medindia
Why Register as Premium Member if you have Hypertension? Click Here
Medindia » Health Watch

Coffee Lowers Risk of Chronic Liver Disease

by Colleen Fleiss on June 22, 2021 at 1:40 PM
Listen to this News

Highlights:

Coffee (caffeinated or decaffeinated) consumption is linked to a reduced risk of developing chronic liver disease and related liver conditions, stated a new study published in the open access journal BMC Public Health. The study was conducted by researchers at the Universities of Southampton and Edinburgh, UK.


The authors studied UK Biobank data on 495,585 participants with known coffee consumption, who were followed over a median of 10.7 years to monitor who developed chronic liver disease and related liver conditions.

‘Drinking any type of coffee was associated with a reduced risk of developing and dying from chronic liver disease compared to not drinking coffee, with the benefit peaking at three to four cups per day.’

Of all participants included in the study, 78% (384,818) consumed ground or instant caffeinated or decaffeinated coffee, while 22% (109,767) did not drink any type of coffee. During the study period, there were 3,600 cases of chronic liver disease, including 301 deaths. Additionally, there were 5,439 cases of chronic liver disease or steatosis (a build of up fat in the liver also known as fatty liver disease), and 184 cases of Hepatocellular carcinoma, a type of liver cancer.

Compared to non-coffee drinkers, coffee-drinkers had a 21% reduced risk of chronic liver disease, a 20% reduced risk of chronic or fatty liver disease, and a 49% reduced risk of death from chronic liver disease. The maximum benefit was seen in the group who drank ground coffee, which contains high levels of the ingredients Kahweol and cafestol, which have been shown to be beneficial against chronic liver disease in animals.

While the reduction in risk was smaller than that associated with ground coffee, the finding may suggest that other ingredients, or potentially a combination of ingredients, may be beneficial. Dr Oliver Kennedy, the lead author said: "Coffee is widely accessible and the benefits we see from our study may mean it could offer a potential preventative treatment for chronic liver disease. This would be especially valuable in countries with lower income and worse access to healthcare and where the burden of chronic liver disease is highest."

The authors caution that, as coffee consumption was only reported when participants first enrolled in the study, the study does not account for any changes in the amount or type of coffee they consumed over the 10.7-year study period. As participants were predominantly white and from a higher socio-economic background, the findings may be difficult to generalise to other countries and populations.

The authors suggest that future research could test the relationship between coffee and liver disease with more rigorous control of the amount of coffee consumed. They also propose validating their findings in more diverse groups of participants.

Source: Eurekalert

Cite this Article

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Colleen Fleiss. (2021, June 22). Coffee Lowers Risk of Chronic Liver Disease. Medindia. Retrieved on Jul 03, 2024 from https://www.medindia.net/news/healthwatch/coffee-lowers-risk-of-chronic-liver-disease-201857-1.htm.

  • MLA

    Colleen Fleiss. "Coffee Lowers Risk of Chronic Liver Disease". Medindia. Jul 03, 2024. <https://www.medindia.net/news/healthwatch/coffee-lowers-risk-of-chronic-liver-disease-201857-1.htm>.

  • Chicago

    Colleen Fleiss. "Coffee Lowers Risk of Chronic Liver Disease". Medindia. https://www.medindia.net/news/healthwatch/coffee-lowers-risk-of-chronic-liver-disease-201857-1.htm. (accessed Jul 03, 2024).

  • Harvard

    Colleen Fleiss. 2021. Coffee Lowers Risk of Chronic Liver Disease. Medindia, viewed Jul 03, 2024, https://www.medindia.net/news/healthwatch/coffee-lowers-risk-of-chronic-liver-disease-201857-1.htm.

View Non AMP Site | Back to top ↑